India has launched two special category visa for international students intending to pursue higher education in academic institutions in the country. Image only for representation. Photograph:......
Chief Executive Officer of Serum Institute of India, Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021, and of the total......
A first information report (FIR) was launched against some unidentified persons for cheating the Serum Institute of India for more than Rs 1 crore, said the officials on Sunday. IMAGE: Adar......
The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for ‘examination, test, and analysis’,......
Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income......
Stocks of Oxford COVID-19 vaccine, Covishield, are likely to start moving out of Serum Institute of India's facility here on early Tuesday morning, days ahead of the nationwide inoculation drive,......
Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......